2. Academic Validation
  3. PCSK9 aggravated carotid artery stenosis in ApoE-/- mice by promoting the expression of tissue factors in endothelial cells via the TLR4/NF-κB pathway

PCSK9 aggravated carotid artery stenosis in ApoE-/- mice by promoting the expression of tissue factors in endothelial cells via the TLR4/NF-κB pathway

  • Biochem Pharmacol. 2024 May 24:225:116314. doi: 10.1016/j.bcp.2024.116314.
Chao Peng 1,  Jian Li 2,  Yan Chen 3,  Heng-Rui Zhang 4,  Tian-Xing Li 5,  Yu-Hang Jiang 6,  Xin-Yu Yang 7,  Yan Zhao 8
Affiliations

Affiliations

  • 1 Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, PR China. Electronic address: pengchao3892@163.com.
  • 2 Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, PR China. Electronic address: lijian1011s@tmu.edu.cn.
  • 3 Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, PR China. Electronic address: chenyan19998@163.com.
  • 4 Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, PR China. Electronic address: zhanghengrui@tmu.edu.cn.
  • 5 Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, PR China. Electronic address: ltxsmm@163.com.
  • 6 Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, PR China. Electronic address: jiangbao@tmu.edu.cn.
  • 7 Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, PR China. Electronic address: yangxinyu@tmu.edu.cn.
  • 8 Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, PR China. Electronic address: tjmuzhaoyan@163.com.
PMID: 38797271 DOI: 10.1016/j.bcp.2024.116314
Abstract

Atherosclerosis, a chronic inflammatory disease, is the most relevant cause of carotid artery stenosis. Vascular endothelial cells (ECs) play a significant role in the development of atherosclerosis. In this chronic inflammatory environment, we aimed to investigate whether PCSK9 could mitigate atherosclerosis progression by reducing tissue factor expression in ECs via in vivo and in vitro assays. In vivo, we investigated the effect of PCSK9 inhibition on preventing atherosclerotic lesion formation in apoE-/- mice fed a western diet. The results showed that inhibiting PCSK9 could significantly downregulate the protein expression of tissue factor (TF) in ECs to reduce the area of atherosclerotic plaques. In vitro, we incubated human umbilical vein endothelial cells (HUVECs) with lipopolysaccharide (LPS). We found that LPS-induced TF elevation was suppressed by a PCSK9 Inhibitor at both the mRNA and protein levels and that the TLR4/NF-κB pathway was also suppressed by a PCSK9 Inhibitor. With respect to plasma samples from patients with carotid artery stenosis, we also demonstrated that the expression of TF was positively correlated with that of PCSK9. Thus, in addition to regulating lipid metabolism, the regulation of endothelial cell TF expression through the TLR4/NF-κB pathway may be a potential mechanism of PCSK9 in promoting atherosclerotic carotid stenosis.

Keywords

Atherosclerosis; Carotid artery stenosis; Endothelial cells; Proprotein convertase subtilisin/kexin type 9; Tissue factor.

Figures
Products
Inhibitors & Agonists
Other Products